# OnCo record eortc-h10 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/eortc-h10/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "eortc-h10", "NCT00433433" ;
  schema:name "EORTC/LYSA/FIL H10"@en ;
  schema:alternateName "H10"@en, "EORTC H10"@en, "Early positron emission tomography response-adapted treatment in early Hodgkin lymphoma"@en ;
  schema:description "In early Hodgkin lymphoma, people whose scan was still positive after two rounds did much better on more intensive chemotherapy, and people whose scan was clear still needed their radiotherapy."@en ;
  schema:url <https://onco.cc/trials/eortc-h10/> ;
  schema:dateModified "2026-10-01"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00433433>, <https://doi.org/10.1200/JCO.2016.68.6394> ;
  onco:status "mixed" ;
  onco:tag "lymphoma-evidence" ;
  onco:phase "3" ;
  schema:startDate "2006-10" ;
  onco:cancers <https://onco.cc/cancers/early-stage-classical-hodgkin-lymphoma/>, <https://onco.cc/cancers/hodgkin-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/radiation/>, <https://onco.cc/fronts/chemotherapy/>, <https://onco.cc/fronts/imaging/> ;
  onco:technologies <https://onco.cc/technologies/pet-ct/>, <https://onco.cc/terms/radiotherapy/>, <https://onco.cc/technologies/imrt-igrt/> ;
  onco:drugs <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/bleomycin/>, <https://onco.cc/drugs/vinblastine/>, <https://onco.cc/drugs/dacarbazine/>, <https://onco.cc/drugs/etoposide/>, <https://onco.cc/drugs/cyclophosphamide/>, <https://onco.cc/drugs/vincristine/>, <https://onco.cc/drugs/procarbazine/>, <https://onco.cc/drugs/prednisone/> ;
  onco:terms <https://onco.cc/terms/deauville-score/>, <https://onco.cc/terms/abvd-beacopp/>, <https://onco.cc/terms/non-inferiority/> ;
  onco:trials <https://onco.cc/trials/hd16/>, <https://onco.cc/trials/hd10/>, <https://onco.cc/trials/rathl/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-survivorship/>, <https://onco.cc/bottlenecks/b-toxicity-qol/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-eortc-h10-pet-adapted-early-hodgkin-jco-2017/> .